Arian Lundberg, PhD

Title(s)Postdoctoral Scholar, Radiation Oncology
SchoolSchool of Medicine
Address1450 Third Street, #262
San Francisco CA 94158
Emailarian.lundberg@ucsf.edu
ORCID ORCID Icon0000-0002-6630-2787 Additional info
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Lund University, SwedenMSc11/2012Bioinformatics
    Stockholm University, SwedenMSc10/2014Computational Biophysics/Biochemistry (Bioinformatics)
    Uppsala University, Sweden12/2014Pharmaceutical Bioinformatics
    Karolinska Insitutet, SwedenPhD.02/2019Medical Sciences
    Stanford University, USAPostdoc06/2020Bioinformatics
    Collapse Awards and Honors
    University of California, San Francisco2022  - 2023Prostate Cancer Research Pilot Grant

    Collapse Overview 
    Collapse Overview
    As a Ph.D. holder in Medical Bioinformatics with a focus on transcriptional gene expression signatures in breast cancer, I have extensive knowledge and experience in the field of cancer research. During my time at Stanford University, I worked in Dr. Li's lab to study the functions of tertiary lymphoid structures in the tumour microenvironment, with the goal of identifying cancer patients who may respond better to immune checkpoint blockades.

    Currently, I am working in Prof. Feng's lab at the Department of Radiation Oncology of UCSF, where I continue to advance my knowledge and skills in the field of cancer research. I am highly motivated and dedicated to improving our understanding of cancer, and to ultimately improving patient outcomes.

    Collapse Research 
    Collapse Research Activities and Funding
    Investigating the Association Between Microbiota Dysbiosis and Patient’s Survival in Advanced Prostate Cancer
    UCSF Prostate Cancer Program Jul 1, 2022 - Jun 30, 2022
    Role: Awardee

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Featured Content 
    Collapse Twitter

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. The genomic and epigenomic landscape of double-negative metastatic prostate cancer. Cancer Res. 2023 Jun 08. Lundberg A, Zhang M, Aggarwal R, Li H, Zhang L, Foye A, Sjöström M, Chou J, Chang K, Moreno-Rodriguez T, Shrestha R, Baskin A, Zhu X, Weinstein AS, Younger N, Alumkal JJ, Beer TM, Chi KN, Evans CP, Gleave M, Lara PN, Reiter RE, Rettig MB, Witte ON, Wyatt AW, Feng FY, Small EJ, Quigley DA. PMID: 37289025.
      View in: PubMed   Mentions:
    2. Intrinsic Molecular Subtypes of Metastatic Castration-Resistant Prostate Cancer. Clin Cancer Res. 2022 12 15; 28(24):5396-5404. Feng E, Rydzewski NR, Zhang M, Lundberg A, Bootsma M, Helzer KT, Lang JM, Aggarwal R, Small EJ, Quigley DA, Sjöström M, Zhao SG. PMID: 36260524; PMCID: PMC9890931.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    3. The 5-Hydroxymethylcytosine Landscape of Prostate Cancer. Cancer Res. 2022 11 02; 82(21):3888-3902. Sjöström M, Zhao SG, Levy S, Zhang M, Ning Y, Shrestha R, Lundberg A, Herberts C, Foye A, Aggarwal R, Hua JT, Li H, Bergamaschi A, Maurice-Dror C, Maheshwari A, Chen S, Ng SWS, Ye W, Petricca J, Fraser M, Chesner L, Perry MD, Moreno-Rodriguez T, Chen WS, Alumkal JJ, Chou J, Morgans AK, Beer TM, Thomas GV, Gleave M, Lloyd P, Phillips T, McCarthy E, Haffner MC, Zoubeidi A, Annala M, Reiter RE, Rettig MB, Witte ON, Fong L, Bose R, Huang FW, Luo J, Bjartell A, Lang JM, Mahajan NP, Lara PN, Evans CP, Tran PT, Posadas EM, He C, Cui XL, Huang J, Zwart W, Gilbert LA, Maher CA, Boutros PC, Chi KN, Ashworth A, Small EJ, He HH, Wyatt AW, Quigley DA, Feng FY. PMID: 36251389; PMCID: PMC9627125.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    4. Reclassifying tumour cell cycle activity in terms of its tissue of origin. NPJ Precis Oncol. 2022 Aug 20; 6(1):59. Lundberg A, Yi JJJ, Lindström LS, Tobin NP. PMID: 35987928; PMCID: PMC9392789.
      View in: PubMed   Mentions: 1  
    5. B cell-related gene signature and cancer immunotherapy response. Br J Cancer. 2022 04; 126(6):899-906. Lundberg A, Li B, Li R. PMID: 34921229; PMCID: PMC8927337.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    6. A pan-cancer analysis of the frequency of DNA alterations across cell cycle activity levels. Oncogene. 2020 08; 39(32):5430-5440. Lundberg A, Lindström LS, Parker JS, Löverli E, Perou CM, Bergh J, Tobin NP. PMID: 32581248; PMCID: PMC8159764.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    7. The long-term prognostic and predictive capacity of cyclin D1 gene amplification in 2305 breast tumours. Breast Cancer Res. 2019 02 28; 21(1):34. Lundberg A, Lindström LS, Li J, Harrell JC, Darai-Ramqvist E, Sifakis EG, Foukakis T, Perou CM, Czene K, Bergh J, Tobin NP. PMID: 30819233; PMCID: PMC6394106.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    8. Gene Expression Signatures and Immunohistochemical Subtypes Add Prognostic Value to Each Other in Breast Cancer Cohorts. Clin Cancer Res. 2017 Dec 15; 23(24):7512-7520. Lundberg A, Lindström LS, Harrell JC, Falato C, Carlson JW, Wright PK, Foukakis T, Perou CM, Czene K, Bergh J, Tobin NP. PMID: 28972043; PMCID: PMC5822691.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    9. PAM50 Provides Prognostic Information When Applied to the Lymph Node Metastases of Advanced Breast Cancer Patients. Clin Cancer Res. 2017 Dec 01; 23(23):7225-7231. Tobin NP, Lundberg A, Lindström LS, Harrell JC, Foukakis T, Carlsson L, Einbeigi Z, Linderholm BK, Loman N, Malmberg M, Fernö M, Czene K, Perou CM, Bergh J, Hatschek T, TEX Trialists Group. PMID: 28972041; PMCID: PMC5822712.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    With one click, see people who:

    Mentor Faculty

    Offer Student Projects

    Run Clinical Trials

    Work in Global Health Equity

    See more options in the Advanced Search tab

    Arian's Networks
    Concepts (44)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (22)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version pre_new_search-4-g7119b7be on PROFILES-PWEB04.

    Copyright © The Regents of the University of California.